How much protein do FSHD patients really need? new study aims to find out

NCT ID NCT06785428

Completed Knowledge-focused Sponsor: McGill University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study looks at how much protein adults with facioscapulohumeral muscular dystrophy (FSHD) need each day to support muscle health. Researchers will test different amino acid intakes in 10 participants using a non-invasive technique. The goal is to improve dietary recommendations for people with FSHD, who often have progressive muscle loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Amino acid intake (dietary supplement)
What this could lead to: If successful, this could lead to better dietary protein recommendations for people with FSHD, helping them maintain muscle strength and function.
What could go wrong: This is a small, early-stage study with only 10 participants, so results may not apply to everyone with FSHD. It measures protein needs, not a treatment or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

facioscapulohumeral muscular dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

Contacts and locations

Show contact details

Locations

McGill university

Montreal, Quebec, H2W 1S4, Canada
McGill university

Montreal, Quebec, H3A 0G4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.